Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Does Royal Philips (PHG) have what it takes to be a top stock pick for momentum investors? Let's find out.
Investors with an interest in Medical - Products stocks have likely encountered both Royal Philips (PHG) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks presents investors with the better value opportunity right now?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Investors looking for stocks in the Medical - Products sector might want to consider either Royal Philips (PHG) or EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks offers value investors a better bang for their buck right now?
Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) has appointed Alan Huang, formerly of Philips Healthcare, as the firm's new sales vice president. Having served at Philips for 12 years and as its MRI business units' North American head most recently, Huang joins Polaren following over a year of collaboration between the two firms.
Philips (PHG) extends its partnership Isala hospital to optimize the latter's healthcare processes, expanding its customer base.
Philips' (PHG) second-quarter results benefit from strong momentum across the Diagnosis & Treatment, Connected Care and Personal Health businesses.
We recap the Q2 earnings report from Philips highlighted by comparable sales growth and a rebound in new orders. The company is settling litigation related to the global safety recall of its defective respiratory sleep apnea products. Improving financials and declining uncertainties support a positive outlook for the stock.